Dasatinib in Resectable Malignant Pleural Mesothelioma

NCT00652574 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

DRUG: Dasatinib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]